Menu

Blog

Page 1404

Jan 27, 2024

Untethered Micro/Nanorobots for Remote Sensing: Toward Intelligent Platform

Posted by in categories: innovation, robotics/AI

Untethered micro/nanorobots that can wirelessly control their motion and deformation state have gained enormous interest in remote sensing applications due to their unique motion characteristics in various media and diverse functionalities. Researchers are developing micro/nanorobots as innovative tools to improve sensing performance and miniaturize sensing systems, enabling in situ detection of substances that traditional sensing methods struggle to achieve. Over the past decade of development, significant research progress has been made in designing sensing strategies based on micro/nanorobots, employing various coordinated control and sensing approaches. This review summarizes the latest developments on micro/nanorobots for remote sensing applications by utilizing the self-generated signals of the robots, robot behavior, microrobotic manipulation, and robot-environment interactions.

Jan 27, 2024

Outcomes in Takotsubo Syndrome and Associations with Medication Use

Posted by in category: biotech/medical

Patients with takotsubo syndrome in a new study had elevated cardiovascular and noncardiovascular death rates. Inhibitors of the renin-angiotensin system were the only cardiovascular medications associated with reduced risk.


In takotsubo syndrome (TS) — also called stress cardiomyopathy or broken heart syndrome — long-term mortality is elevated, similar to that after acute myocardial infarction (AMI), but for unclear reasons. Additionally, evidence-based therapies are lacking for TS. To explore causes of death and the effects of heterogeneous therapies for TS, investigators in Scotland compared outcomes between 620 patients with TS, 620 matched patients presenting with AMI, and 2,480 matched individuals from the general population. Median follow-up was 5.5 years.

Among patients with TS, all-cause mortality was higher compared with the general population (hazard ratio, 1.8), both for cardiovascular causes (HR, 2.5) and noncardiovascular causes (HR, 1.5), but was lower compared with patients with AMI (HR, 0.8). Patients with TS were prescribed cardiovascular and noncardiovascular medications at similar rates to those with AMI. Use of diuretics, anti-inflammatory agents, and psychotropic agents were associated with higher mortality in patients with TS, as was chronic anti-inflammatory medication use. The only medications associated with lower mortality in patients with TS were inhibitors of the renin-angiotensin system.

Continue reading “Outcomes in Takotsubo Syndrome and Associations with Medication Use” »

Jan 27, 2024

Healthy eating and activity reverse aging marker in kids with obesity, study finds

Posted by in categories: biotech/medical, food, genetics, life extension

A genetic marker linked to premature aging was reversed in children with obesity during a six-month diet and exercise program, according to a recent study led by the Stanford School of Medicine.

Children’s telomeres—protective molecular “caps” on the chromosomes—were longer during the weight management program, then were shorter again in the year after the program ended, the study found. The research was published last month in Pediatric Obesity.

Like the solid segment at the end of a shoelace, telomeres protect the ends of chromosomes from fraying. In all people, telomeres gradually shorten with aging. Various conditions, including obesity, cause premature shortening of the telomeres.

Jan 27, 2024

Giant ring? Giant arc? These “structures” may not even be real

Posted by in category: space

Astronomers claim to have found structures so large, they shouldn’t exist. With such biased, incomplete observations, perhaps they don’t.

Jan 27, 2024

Scientist Counters Einstein’s Relativity Theory, Claims He’s ‘Fixed’ Flaws

Posted by in category: futurism

In his new gravitational model, the researcher started from the so-called Gibbs-Duhem relation that is used in thermodynamics to describe changes in a system.

Jan 27, 2024

Right again, Einstein: New snapshot of 1st black hole to be photographed confirms relativity

Posted by in categories: cosmology, physics

The new black hole image offers further confirmation for Albert Einstein’s theory of general relativity.

Jan 27, 2024

Watch a robot made of muscle and steel turn on a dime

Posted by in category: robotics/AI

Once mostly limited to straight-line motion, “biohybrid” bots are finally getting the hang of more complex motion.

Jan 27, 2024

Optimizing Gene Editing with PARP1 CRISPR Plasmids

Posted by in categories: bioengineering, biotech/medical, genetics, health

Gene editing is revolutionizing the understanding of health and disease, providing researchers with vast opportunities to advance the development of novel treatment approaches. Traditionally, researchers used various methods to introduce double strand breaks (DSBs) into the genome, including transactivator-like effectors, meganucleases, and zinc finger nucleases. While useful, these techniques are limited in that they are time and labor intensive, less efficient, and can have unintended effects. In contrast, the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein-9 (Cas9) system (CRISPR/Cas9) is among the most sensitive and efficient methods for creating DNA DSBs, making it the leading gene editing technology.

CRISPR/Cas9 is a naturally occurring immune protective process that bacteria use to destroy foreign genetic material.1 Researchers repurposed the CRISPR/Cas9 system for genetic engineering applications in mammalian cells, exploiting the molecular processes that introduce DSBs in specific sections of DNA, which are then repaired to turn certain genes on or off, or to correct genomic errors with extraordinary precision.2,3 This technology’s applications are far reaching, from cell culture and animal models to translational research that focuses on correcting genetic mutations in diseases such as cancer, hemophilia, and sickle cell disease.4

Researchers exploit plasmids, the small, closed circular DNA strands native to bacteria, as delivery vehicles in CRISPR/Cas9 gene editing protocols. Plasmids shuttle the CRISPR/Cas9 gene editing components to target cells and can be manipulated to control gene editing activity, including targeting multiple genes at a time. Plasmids can also deliver gene repair instructions and machinery. For example, poly (ADP-ribose) polymerase 1 (PARP1) is an enzyme that drives DNA repair and transcription.5 It is a critical aspect of CRISPR/Cas9 gene editing technology in part because it helps repair the DSBs created by the CRISPR/Cas9 system. PARP1 CRISPR plasmids can edit, knockout, or upregulate PARP1 gene expression depending on the specific instructions encoded in the plasmid.

Jan 27, 2024

Can quantum hints in the brain revive a radical consciousness theory?

Posted by in categories: neuroscience, quantum physics

With anaesthetics and brain organoids, we are finally testing the idea that quantum effects explain consciousness – and the early results suggest this long-derided idea may have been misconstrued.

By George Musser

Jan 27, 2024

Elon Musk confirms a new low-cost Tesla model is coming in 2025

Posted by in categories: Elon Musk, sustainability, transportation

Tesla is reportedly working on compact crossover EV codenamed “Redwood” with production set to start in June 2025, sources familiar with the matter told Reuters. The company is said to have sent requests for quotes for the new model to suppliers last year, predicting a weekly production volume of 10,000 vehicles.


Elon Musk has confirmed that a “next-generation low-cost” Tesla EV is in the works and is “optimistic” that it’ll arrive in the second half of 2025, he said in an earnings call yesterday. He also promised “a revolutionary manufacturing system” for the vehicle that’s far more advanced than any others in the world by a “significant margin.”

An article yesterday from Reuters indicated that the new vehicle would be a small crossover codenamed “Redwood.” Tesla reportedly sent requests to suppliers for quotes, predicting a weekly production volume of 10,000 vehicles. Musk previously stated that the automaker is working on two new EV models that could sell up to 5 million per year, combined.

Continue reading “Elon Musk confirms a new low-cost Tesla model is coming in 2025” »